Full Text View
Tabular View
No Study Results Posted
Related Studies
TBE Seropersistence up to 10 Years After First Booster in Adults
This study is ongoing, but not recruiting participants.
Study NCT01582698   Information provided by Baxter Healthcare Corporation

First Received on April 20, 2012.   Last Updated on September 28, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tick-borne Encephalitis (TBE)
Additional conditions recognized in this trial
Encephalitis
Encephalitis, Tick-Borne
More general conditions related to this trial
Arbovirus Infections
Brain Diseases
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Encephalitis, Arbovirus
Encephalitis, Viral
Flaviviridae Infections
Flavivirus Infections
Nervous System Diseases
RNA Virus Infections
Tick-Borne Diseases
Virus Diseases
Interventions listed in this trial
FSME-IMMUN 0.5 ml
Additional drug interventions recognized in this trial
Antibodies
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Baxter Healthcare Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services